Perceptive Advisors LLC Oncorus, Inc. Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.04 - $1.86 $782,330 - $1.4 Million	-752,241 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.44 - $5.62 $356,502 - $1.39 Million	-247,571 Reduced 24.76%	752,241 $1.34 Million
Q4 2021 Feb 14, 2022	SELL	$5.03 - $11.63 $502,989 - $1.16 Million	-99,998 Reduced 9.09%	999,812 $5.27 Million
Q3 2021 Nov 15, 2021	SELL	$9.29 - $14.27 $3.38 Million - $5.19 Million	-363,789 Reduced 24.86%	1,099,810 $10.3 Million
Q2 2021 Aug 16, 2021	SELL	$13.3 - $17.3 $7 Million - $9.11 Million	-526,388 Reduced 26.45%	1,463,599 $20.2 Million
Q4 2020 Feb 16, 2021	BUY	$15.0 - $35.15 $29.8 Million - $69.9 Million	1,989,987 New	1,989,987 $64.3 Million

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.